Molecular modeling as a tool for drug discovery
- PMID: 19128219
- DOI: 10.2174/138945008786949388
Molecular modeling as a tool for drug discovery
Abstract
With the progression of structural genomics projects, comparative modeling remains an increasingly important method of choice to obtain 3D structure of proteins. It helps to bridge the gap between the available sequence and structure information by providing reliable and accurate protein models. Comparative modeling based on more than 30% sequence identity is now approaching its natural template-based limits and further improvements require the development of effective refinement techniques capable of driving models toward native structure. For difficult targets, for which the most significant progress in recent years has been observed, optimal template selection and alignment accuracy are still the major problems. The past year has seen a maturation of molecular modeling, with an increasing number of comparative studies between established methods becoming possible, together with an explosion of new works especially in the areas of combinatorial chemistry and molecular diversity. To achieve this, knowledge about three-dimensional protein structures is crucial for the understanding of their functional mechanisms, and for a rational drug design. This review described recent progress in molecular modeling methodology.
Similar articles
-
Comparative modeling for protein structure prediction.Curr Opin Struct Biol. 2006 Apr;16(2):172-7. doi: 10.1016/j.sbi.2006.02.003. Epub 2006 Feb 28. Curr Opin Struct Biol. 2006. PMID: 16510277 Review.
-
Homology modeling: an important tool for the drug discovery.J Biomol Struct Dyn. 2015;33(8):1780-93. doi: 10.1080/07391102.2014.971429. Epub 2014 Nov 6. J Biomol Struct Dyn. 2015. PMID: 25266493
-
Comparative modeling of proteins.Methods Mol Biol. 2008;443:199-212. doi: 10.1007/978-1-59745-177-2_11. Methods Mol Biol. 2008. PMID: 18446289
-
The eradication of leprosy: molecular modeling techniques for novel drug discovery.Expert Opin Drug Discov. 2013 Oct;8(10):1239-51. doi: 10.1517/17460441.2013.826188. Epub 2013 Aug 7. Expert Opin Drug Discov. 2013. PMID: 23924296 Review.
-
Comparative modeling of proteins.Methods Mol Biol. 2015;1215:309-30. doi: 10.1007/978-1-4939-1465-4_14. Methods Mol Biol. 2015. PMID: 25330969
Cited by
-
A combined molecular modeling study on a series of pyrazole/isoxazole based human Hsp90α inhibitors.J Mol Model. 2011 Dec;17(12):3241-50. doi: 10.1007/s00894-011-1011-x. Epub 2011 Mar 4. J Mol Model. 2011. PMID: 21369933
-
Molecular modeling and dynamics studies of purine nucleoside phosphorylase from Bacteroides fragilis.J Mol Model. 2009 Aug;15(8):913-22. doi: 10.1007/s00894-008-0445-2. Epub 2009 Jan 27. J Mol Model. 2009. PMID: 19172318
-
Molecular dynamics studies of a hexameric purine nucleoside phosphorylase.J Mol Model. 2010 Mar;16(3):543-50. doi: 10.1007/s00894-009-0557-3. Epub 2009 Aug 11. J Mol Model. 2010. PMID: 19669809
-
Update of TTD: Therapeutic Target Database.Nucleic Acids Res. 2010 Jan;38(Database issue):D787-91. doi: 10.1093/nar/gkp1014. Epub 2009 Nov 20. Nucleic Acids Res. 2010. PMID: 19933260 Free PMC article.
-
DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.PLoS One. 2011 Feb 2;6(2):e16691. doi: 10.1371/journal.pone.0016691. PLoS One. 2011. PMID: 21311763 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous